Terminated NA INTERVENTIONAL 2-arm NCT04665440

Response of Preterm Infants to Multisensory Stimuli (OXYVOICE)

Variation of Salivary Oxytocin and Cortisol Levels in Premature Neonates and Their Mothers in Response to Multi-sensory Stimuli

Sponsor: University Hospital, Geneva

Conditions Mother-Infant Interaction

Interventions Voice + tactile stimuli Voice alone

Updated 4 times since 2021 Last updated: May 8, 2023 Started: Sep 1, 2020 Primary completion: Nov 3, 2022 Completion: Nov 3, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

slow recruitment

Other terminated trials from University Hospital, Geneva

See all terminations from University Hospital, Geneva

Listed as NCT04665440, this NA trial focuses on Mother-Infant Interaction and remains terminated or withdrawn. Sponsored by University Hospital, Geneva, it has been updated 4 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jun 2023 — Jul 2024 [monthly]

Terminated NA

Status: Recruiting → Terminated
Jan 2021 — Jun 2023 [monthly]

Recruiting NA

First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Geneva

Data source: University Hospital, Geneva

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Geneva, Switzerland